Cycloserine

In the US, Cycloserine (cycloserine systemic) is a member of the drug class streptomyces derivatives and is used to treat Tuberculosis - Active and Tuberculosis - Extrapulmonary.

US matches:

• Cycloserine

UK matches:

• CYCLOSERINE (King Pharmaceuticals Ltd) (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AB01

CAS registry number (Chemical Abstracts Service)

0000068-41-7

Chemical Formula

C3-H6-N2-O2

Molecular Weight

102

Therapeutic Categories

Antibacterial

Antitubercular agent

Chemical Name

3-Isoxazolidinone, 4-amino-, (R)-

Foreign Names

• Cycloserinum (Latin)
• Cycloserin (German)
• Cyclosérine (French)
• Cicloserina (Spanish)

Generic Names

• Cycloserine (OS: BAN)
• Cyclosérine (OS: DCF)
• Lilly 106-7 (IS)
• MK 65 (IS)
• PA 94 (IS)
• Ro 1-9213 (IS)
• SC 49088 (IS: Searle)
• Cicloserina (PH: F.U. IX)
• Cycloserine (PH: JP XV, USP 32, BP 1988)
• Cycloserinum (PH: Ph. Int. 2)

Brand Names

• Coxerin
  Macleods, Georgia



• Cyclorine
  Lupin, India



• Cycloserine Meji
  Meiji, Hong Kong; Meiji, Thailand



• Cycloserine
  Aspen, Australia; Biopharm, Russian Federation; King Pharmaceuticals, United Kingdom; Lilly, Israel; Lilly, Russian Federation



• Helpocerin
  Help, Romania



• Neoseryn
  AC Farma, Peru



• Seromycin
  Purdue Pharma, United States



• Siklocap
  Koçak, Turkey

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.